Cargando…
Genetic interaction between placental growth factor and vascular endothelial growth factor A in psoriasis
BACKGROUND: Expression of vascular endothelial growth factor A (VEGFA) is increased in chronic inflammatory skin diseases, including psoriasis, and loci for two VEGFA single nucleotide polymorphisms are associated with early‐onset psoriasis (presenting before the age of 40 years). Studies have sugge...
Autores principales: | Young, H. S., Kamaly‐Asl, I. D., Laws, P. M., Pemberton, P., Griffiths, C. E. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154646/ https://www.ncbi.nlm.nih.gov/pubmed/31545526 http://dx.doi.org/10.1111/ced.14102 |
Ejemplares similares
-
Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis
por: Weidemann, Anja K, et al.
Publicado: (2013) -
Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis
Publicado: (1994) -
Inhibition of vascular endothelial growth factor‐A downregulates angiogenesis in psoriasis: A pilot study
por: Luengas‐Martinez, Andrea, et al.
Publicado: (2023) -
Vascular endothelial growth factors and vascular permeability
por: Bates, David O.
Publicado: (2010) -
Association of serum levels of vascular endothelial growth factor and placental growth factor in early threatened abortion and premature delivery: A case‑control study
por: Zhang, Pei, et al.
Publicado: (2023)